FMR1 mRNA from full mutation alleles is associated with ABC-CFX scores in males with fragile X syndrome
Open Access
- 16 July 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-8
Abstract
Fragile X syndrome (FXS) is caused by a hypermethylated full mutation (FM) expansion with ≥ 200 CGG repeats, and a decrease in FMR1 mRNA and its protein. However, incomplete silencing from FM alleles has been associated with more severe autism features in FXS males. This study compared scores on the Aberrant Behavior Checklist-Community-FXS version (ABC-CFX) in 62 males affected with FXS (3 to 32 years) stratified based on presence or absence of mosaicism and/or FMR1 mRNA silencing. Associations between ABC-CFX subscales and FMR1 mRNA levels, assessed using real-time PCR relative standard curve method, were also examined. The FXS group mosaic for premutation (PM: 55–199 CGGs) and FM alleles had lower irritability (p = 0.014) and inappropriate speech (p < 0.001) scores compared to males with only FM alleles and complete loss of FMR1 mRNA. The PM/FM mosaic group also showed lower inappropriate speech scores compared to the incomplete silencing (p = 0.002) group. Increased FMR1 mRNA levels were associated with greater irritability (p < 0.001), and lower health-related quality of life scores (p = 0.004), but only in the incomplete silencing FM-only group. The findings suggest that stratification based on CGG sizing and FMR1 mRNA levels may be warranted in future research and clinical trials utilising ABC-CFX subscales as outcome measures.Keywords
Funding Information
- National Health and Medical Research Council (1103389)
- Financial Markets Foundation for Children (2017 – 361)
- Medical Research Future Fund (MRF1141334)
This publication has 34 references indexed in Scilit:
- Intranuclear inclusions in a fragile X mosaic maleTranslational Neurodegeneration, 2013
- Clinic-Based Retrospective Analysis of Psychopharmacology for Behavior in Fragile X SyndromeInternational Journal of Pediatrics, 2012
- Testing the FMR1 Promoter for Mosaicism in DNA Methylation among CpG Sites, Strands, and Cells in FMR1-Expressing Males with Fragile X SyndromePLOS ONE, 2011
- Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the mGluR5 Antagonist AFQ056Science Translational Medicine, 2011
- Improved Methodology for Assessment of mRNA Levels in Blood of Patients with FMR1 Related DisordersBMC Clinical Pathology, 2009
- An improved Diagnostic PCR Assay for identification of Cryptic Heterozygosity for CGG Triplet Repeat Alleles in the Fragile X Gene (FMR1)Molecular Cytogenetics, 2008
- A majority of fragile X males with methylated, full mutation alleles have significant levels of FMR1messenger RNAJournal of Medical Genetics, 2001
- Genotype, molecular phenotype, and cognitive phenotype: Correlations in fragile X syndromeAmerican Journal of Medical Genetics, 1999
- Absence of expression of the FMR-1 gene in fragile X syndromeCell, 1991
- Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndromeCell, 1991